BioCrossroads 2020 Annual Report

Facebook
Twitter
This post was originally published on this site

While COVID-19 made and continues to make the headlines, Indiana’s life sciences industry not only combatted the pandemic with testing, treatments, clinical trials, and vaccine manufacturing, but also remained committed to delivering medical breakthroughs in other areas. Indiana life sciences start-ups garnered a record high level of investment with more than $262 million going to 44 companies. That’s nearly$100 million more than 2019’s milestone of $171 million.

The post BioCrossroads 2020 Annual Report appeared first on BioCrossroads.